Yunu
Yunu is a cloud-based clinical trial imaging platform serving cancer centers, pharmaceutical sponsors, and CROs with protocol-guided workflows, real-time dashboards, and ICH E6(R3)-compliant audit tools across 5,000+ trials and 8,000+ sites globally.
- Company typePrivate
- Founded2022
- HeadquartersCary, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Yunu does
Yunu is a privately-held med-tech company that provides a cloud-based clinical trial imaging platform serving cancer centers, pharmaceutical sponsors, and contract research organizations (CROs). The company was formally established in 2022 around proprietary imaging technology originally developed at Massachusetts General Hospital by Dr. Gordon Harris (now Yunu's CSO), with corporate headquarters in Cary, North Carolina. According to company-reported metrics, Yunu manages more than 5,000 active clinical trials across 8,000+ sites globally, serves 400+ life sciences companies, and holds over 25% share of imaging trials listed on clinicaltrials.gov — positioning it as a category leader in oncology trial imaging. The platform serves over 3,000 users across radiology, oncology, and trial roles, with named flagship customers including VCU Massey Comprehensive Cancer Center, Huntsman Cancer Institute / University of Utah, Medical College of Wisconsin, Dana-Farber/Harvard Cancer Center, and Massachusetts General Hospital.
The Yunu Platform delivers protocol-guided imaging workflows enforcing 30+ major response criteria (including RECIST, Lugano, and RANO) with over 300 trial-specific variants, real-time imaging dashboards, immutable audit trails for ICH E6(R3) compliance, and a Universal Integration Portal connecting to downstream EDC systems. The product portfolio includes purpose-built modules: Yunuverse (a connected network enabling cross-institution worklist sharing and reader access), De-ID & Export (site-to-sponsor anonymization), eCRF Builder (sponsor study configuration), Custom Dashboards, and segment-specific deployments for Cancer Centers and Sponsors/CROs. Yunu maintains 21 CFR Part 11, HITRUST CSF, SOC 2 Type II, HIPAA, and GDPR certifications, and reports reducing imaging error rates from 25-50% to under 3% post-adoption while cutting turnaround times from weeks to under 48 hours.
Yunu monetizes through annual enterprise SaaS subscriptions sold via direct field sales, with pricing quote-based and not publicly disclosed. Go-to-market combines relationship-based enterprise selling to NCI-designated cancer centers and large pharma sponsors with a heavy conference presence at SCOPE, ASCO, AACR, JPM, and DPHARM. The company has raised two funding rounds — an institutional round led by First Analysis in September 2022 and an oversubscribed round led by Spring Mountain Capital in May 2025 — both with undisclosed amounts. The leadership team is led by CEO Jeffrey Sorenson (co-founder) with a full C-suite including CTO Gael Kuhn, CMO Lindsay Fleming, CCO Patrick McNamara, and CSO Dr. Gordon Harris. Strategic integration partnerships span Veeva, Florence Healthcare, IgniteData, WCG, and Zelta by Merative, embedding Yunu into the broader eClinical ecosystem.
Yunu firmographics
Firmographics- Name
- Yunu
- Legal name
- Yunu, Inc.
- Website
- https://yunu.io
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Yunu is a cloud-based clinical trial imaging platform serving cancer centers, pharmaceutical sponsors, and CROs with protocol-guided workflows, real-time dashboards, and ICH E6(R3)-compliant audit tools across 5,000+ trials and 8,000+ sites globally.
- Ownership category
- akta.pro rank
Yunu industry classification
Industry- Product category
- Clinical Trial Imaging Software
- NAICS
- Software Publishers (513210), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industries
- AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG), Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ), Quality, Peer Review & Compliance Tools (MQSA/ACR/QA) (HLACALAL)
Keywords
Where Yunu is headquartered
LocationHeadquarters
- HQ city
- Cary
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Yunu business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- SaaS Platform Subscription: Cloud-based platform provided as subscription service to cancer centers, sponsors, and CROs. Delivers imaging workflow management, protocol guidance, and compliance tools as a service with tiered access based on organization type and scale.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise SaaS subscription model |
Go-to-market motion3 records
Distribution channels2 records
Marketing channels5 records
Yunu product offering
Product offeringCore offering
Yunu operates a cloud-based, end-to-end clinical trial imaging platform that harmonizes imaging workflows, data, and compliance from initial scan through trial submission. The platform delivers protocol-guided workflows for 30+ major response criteria with 300+ trial-specific variants, real-time imaging dashboards, immutable audit trails meeting ICH E6(R3), and a connected reader network (Yunuverse). It is offered as a SaaS subscription to cancer centers, pharmaceutical sponsors, and CROs with role-based access and integrations to leading eClinical platforms including Florence Healthcare, IgniteData, Veeva, and Zelta by Merative.
Product overview
Yunu is a cloud-based clinical trial imaging platform offering a unified, end-to-end solution for managing imaging workflows across sites, sponsors, and CROs. The core Yunu Platform serves as the foundational system, supporting protocol-guided reads for 30+ response criteria and delivering ICH E6(R3) compliant, audit-ready imaging data. The portfolio includes purpose-specific modules: Yunu De-ID & Export (anonymization and site-to-sponsor data sharing), Yunuverse (networked reader collaboration), and Yunu for Sponsors/CROs and Yunu for Cancer Centers (segment-specific deployments). Recent additions include eCRF Builder, Custom Dashboards, and Universal Integration Portal enabling sponsor-level study configuration and integration with eClinical ecosystems. The platform integrates with leading eClinical tools including Florence Healthcare, IgniteData, Veeva, and Zelta by Merative.
Differentiator
Problem solved
Functional benefit
Brands
- Yunuverse: A connected network of imaging stakeholders that allows trial worklists to move seamlessly between institutions, connecting radiologists, sites, sponsors, and CROs.
Products and services
- Yunu Platform End-to-end cloud-based clinical trial imaging platform that harmonizes imaging workflows, data, and compliance from initial scan through trial submission. Trusted by sponsors and cancer centers to deliver speed, accuracy, and ICH E6(R3) compliance. Supports protocol-guided reads for 30+ major response criteria with over 300 trial-specific variants.
- Yunu De-ID & Export Add-on capability enabling sites to anonymize and export trial images and results directly from existing workflow. Provides streamlined de-identification, role-based permissions, and Subject ID mapping for controlled site-to-sponsor data handoff with greater traceability and less manual effort.
- Yunu eCRF Builder Enables pharma sponsors to configure electronic case report forms and studies in minutes, ensuring imaging consistency and delivering data directly to primary systems.
- Yunu Custom Dashboards Real-time configurable dashboards providing sponsors, CROs, and imaging stakeholders live visibility into read status, site compliance, lesion tracking, imaging queries, and resolution times across all trials and sites.
- Yunu Universal Integration Portal Integration capability enabling streamlined workflows and connectivity with primary systems for site staff, reducing manual data entry and coordination overhead.
- Yunuverse Connected network of imaging stakeholders (readers, radiologists, coordinators) that allows trial worklists to move seamlessly between institutions. Enables cross-institution collaboration, eliminates backlogs and delays, and provides access to trained readers, technologists, and protocol experts on demand.
- Yunu for Sponsors & CROs Trial management solution for sponsors and CROs enabling trial launch in 30 minutes, automated site data collection, enforced accuracy, outsourced reads, BICR, and central review with a click. Provides real-time dashboards, traceability, and ICH E6(R3) compliance.
- Yunu for Cancer Centers Site-level trial imaging solution reducing image management effort by 80%. Unifies reader worklists and structured outputs, automates QC, enforces 30+ imaging response criteria, and provides access to trained readers, technologists, and protocol experts.
- Yunu Central Review Workflow Extension Extension of the Yunu Platform that brings sponsor-specific requirements into workflow logic and creates a unified environment for sites and sponsors with aligned standards, controlled visibility, and consistent execution. Reduces coordination layers and overhead for central review workflows.
Quantifiable outcome
- Error rates reduced from 25-50% to under 3% after Yunu adoption
- +6 more outcomes
Companies that use Yunu
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles2 records
Yunu technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability1 record
Feature7 records
Yunu partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- WCGcoreYunu partnered with WCG (a global leader in clinical trial solutions) and IgniteData to transform clinical trial imaging services. WCG uses Yunu in support of their imaging services, providing integrated real-time platform for WCG's imaging workflows.
- Florence HealthcarecoreIntegration partnership with Florence Healthcare, a leading eClinical platform. Florence integration logo appears on Yunu partners page indicating active integration to ensure imaging fits seamlessly into broader clinical trial ecosystem.
- IgniteDatacoreStrategic partnership announced in February 2025 to improve clinical trial imaging services through an integrated, real-time platform. IgniteData selected Yunu as imaging partner for Top 50 Pharma. Partnership enables seamless EHR-to-EDC integration with imaging data.
- VeevacoreIntegration partnership with Veeva Systems, a leading cloud software company for life sciences. Veeva integration logo appears on Yunu partners page indicating active integration.
Scale indicators12 records
Recent moves6 records
Expansion highlights5 records
Yunu competitors and assessment
Company assessmentBroad incumbents
- Veeva Systems: Veeva is a leading cloud software provider for life sciences with Vault EDC and CTMS products. It is a strategic integration partner of Yunu but also a broad incumbent whose platform could expand into imaging workflows.
- Parexel: Parexel is a global CRO with clinical trial imaging and central imaging review services. It competes broadly with Yunu in imaging-enabled clinical trial delivery for pharma and biotech sponsors.
- ICON plc: ICON is a global CRO offering clinical trial services including imaging core lab capabilities via its Medical Imaging division. It is a broad incumbent that can bundle imaging services into full-service CRO contracts, competing with Yunu for sponsor business.
- Oracle Health Sciences: Oracle Health Sciences offers the Siebel CTMS and clinical trial platforms used by large pharma. It competes broadly with Yunu in trial data management and EDC, while Yunu specializes in imaging.
- Medidata (Dassault Systèmes): Medidata provides the Rave clinical trial platform used by most large pharma sponsors and offers imaging and EDC capabilities. It competes with Yunu at the sponsor/CRO level as part of a broader eClinical suite, while Yunu specializes in imaging-specific workflows.
Emerging players
- Florence Healthcare: Florence Healthcare provides the eBinders eClinical platform connecting sponsors, CROs, and sites. It is an integration partner of Yunu but also an adjacent workflow provider in site-centric clinical trial operations.
Direct peers
- Imaging Endpoints: Imaging Endpoints is a specialized oncology imaging core lab providing central review and imaging services for clinical trials. It competes directly with Yunu's central review and BICR offerings for oncology trial sponsors.
- Clario: Clario is a leading clinical trial technology and imaging endpoint company formed from the merger of ERT and Bioclinica. It directly competes with Yunu in clinical trial imaging workflows, central review, and eCOA/ePRO for pharma and CRO customers.
- Median Technologies: Median Technologies provides iCRO imaging services and AI-based imaging analytics for oncology clinical trials. It is a direct competitor in the oncology trial imaging workflow and central review market.
- Calyx: Calyx (formerly Calyx Clinical Trial Solutions, spun out of ICON) provides imaging management, EDC, and clinical trial technology services. It directly competes with Yunu in trial imaging management for pharma and CRO customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Yunu social profiles
Digital presenceYunu compliance and trust
Trust signalCompliance5 records
Yunu financial estimates
Financial estimateRevenue estimate
Valuation estimate
Yunu leadership team
Management profileNumber of profiles
Profiles12 records
Yunu funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Yunu M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Yunu
What does Yunu do?
Yunu operates a cloud-based, end-to-end clinical trial imaging platform that harmonizes imaging workflows, data, and compliance from initial scan through trial submission. The platform delivers protocol-guided workflows for 30+ major response criteria with 300+ trial-specific variants, real-time imaging dashboards, immutable audit trails meeting ICH E6(R3), and a connected reader network (Yunuverse). It is offered as a SaaS subscription to cancer centers, pharmaceutical sponsors, and CROs with role-based access and integrations to leading eClinical platforms including Florence Healthcare, IgniteData, Veeva, and Zelta by Merative.
Is Yunu a public or private company?
Yunu is a private company. It is classified as venture growth investor backed and is currently operating.
When was Yunu founded?
Yunu was founded in 2022. It employs 11 to 50 people.
Where is Yunu based?
Yunu is headquartered in Cary, United States, in the North America region.
How does Yunu make money?
One revenue line is on record: saaS Platform Subscription.
Who are Yunu's main competitors?
Broad incumbents on record are Veeva Systems, Parexel, ICON plc, Oracle Health Sciences and Medidata (Dassault Systèmes). Florence Healthcare is listed as an emerging player. Direct peers are Imaging Endpoints, Clario, Median Technologies and Calyx.
Does Yunu have an API?
No public API is recorded for Yunu.
What industry is Yunu in?
Yunu's product category is Clinical Trial Imaging Software. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage). Its NAICS code is 513210 and its SIC code is 8731.